IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Endurant Capital Management LP

Q2 2023 Holdings

Filed 2023-08-14 | 34 holdings | $114.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$27.1M6,10023.7%
Biomarin Pharmaceutical Inc(BMRN)CallCOM09061G101$8.1M93,6007.1%
Laboratory Corp Amer HldgsCOM NEW50540R409$7.9M32,5696.9%
The Cigna Group(CI)COM125523100$7.2M25,8166.3%
Merck & Co Inc(MRK)COM58933Y105$5.7M49,3325.0%
Agilent Technologies Inc(A)COM00846U101$5.5M45,7624.8%
Tenet Healthcare Corp(THC)COM NEW88033G407$4.7M58,0364.1%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$4.4M60,8083.8%
Iqvia Hldgs Inc(IQV)COM46266C105$4.3M19,1693.8%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$3.8M43,6023.3%
Becton Dickinson & Co(BDX)COM075887109$3.5M13,3603.1%
Boston Scientific Corp(BSX)COM101137107$3.3M60,9912.9%
Cardinal Health Inc(CAH)COM14149Y108$3.0M31,6962.6%
Qiagen NV(QGEN)SHS NEWN72482123$2.8M62,7082.5%
Elevance Health Inc(ELV)COM036752103$2.5M5,6362.2%
Medtronic PLC(MDT)SHSG5960L103$2.4M27,1812.1%
Encompass Health Corp(EHC)COM29261A100$2.2M32,7101.9%
Ventas Inc(VTR)COM92276F100$2.0M41,5751.7%
Ocular Therapeutix Inc(OCUL)COM67576A100$1.9M368,4381.7%
Insmed Inc(INSM)COM PAR $.01457669307$1.7M79,4711.5%
Teva Pharmaceutical Inds LTD(TEVA)CallSPONSORED ADS881624209$1.3M175,0001.2%
Zoetis Inc(ZTS)CL A98978V103$1.3M7,6431.1%
Bruker Corp(BRKR)COM116794108$1.1M15,2461.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$999.7K2,5650.9%
Bluebird BIO IncCOM09609G100$925.9K281,4410.8%
Selecta Biosciences Inc(SELBUSD)COM816212104$768.5K686,1430.7%
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$759.5K821,0380.7%
Acadia Healthcare Company in(ACHC)COM00404A109$728.9K9,1530.6%
89Bio Inc(ETNBGBP)COM282559103$554.9K29,2820.5%
Orthopediatrics Corp(KIDS)COM68752L100$471.0K10,7410.4%
Masimo Corp(MASI)COM574795100$469.0K2,8500.4%
Bioxcel Therapeutics Inc(BTAIEUR)CallCOM09075P105$380.3K57,1000.3%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$362.9K40,1840.3%
Viking Therapeutics Inc(VKTX)COM92686J106$336.4K20,7540.3%